Endurant Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Endurant Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-123,232	Closed	-$9.98M	–	79
2022 Q1	$9.98M	Buy	123,232 +47,957	+64%	+$4.06M	2.63%	10
2021 Q4	$7.73M	Sell	75,275 -17,486	-19%	-$1.68M	1.87%	17
2021 Q3	$8.12M	Sell	92,761 -37,477	-29%	-$3.39M	1.85%	13
2021 Q2	$11.7M	Buy	130,238 +24,717	+23%	+$2.09M	3.2%	8
2021 Q1	$8M	Buy	105,521 +3,568	+3%	+$269K	2.09%	21
2020 Q4	$6.95M	Sell	101,953 -10,198	-9%	-$636K	2.51%	13
2020 Q3	$5.96M	Buy	112,151 +57,574	+105%	+$3.43M	1.76%	17
2020 Q2	$3.18M	Buy	+54,577	New	+$2.93M	0.17%	31
2018 Q3	–	Sell	-39,198	Closed	-$1.84M	–	86
2018 Q2	$1.84M	Sell	39,198 -153,202	-80%	-$6.34M	0.8%	32
2018 Q1	$6.83M	Buy	192,400 +79,500	+70%	+$3.11M	2.55%	14
2017 Q4	$4.92M	Buy	+112,900	New	+$5.27M	1.5%	30
2017 Q2	–	Sell	-11,200	Closed	-$514K	–	105
2017 Q1	$514K	Buy	+11,200	New	+$557K	0.17%	76

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Endurant Capital Management's SYNH Position: Q2 2022 in Review

Endurant Capital Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2022, closing a stake of 123,232 shares — an estimated $9.98M sold.

Endurant Capital Management first reported a position in SYNH in Q1 2017 and held it in 12 quarters. The position peaked at $11.7M in Q2 2021. 362 funds tracked by Wall St. Rank hold SYNH as of Q2 2022.

Endurant Capital Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
Endurant Capital Management sold 123,232 Syneos Health, Inc. Class A Common Stock shares in Q2 2022, an estimated $9.98M.
Endurant Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 12 quarters.
Endurant Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $11.7M in Q2 2021.
362 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2022.

Based on Endurant Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.